Hexagon Nutrition Limited
MainboardHEXAGON • NSE
Issue details
Price band
₹42 - ₹45
Lot size
333 shares
Issue size
₹139 Cr
Min. investment
₹14,985
Registrar
KFin Technologies
Grey market premium
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
5 Jun
Close
9 Jun
Allotment
10 Jun
Listing
12 Jun
- Refunds & demat credit
- 11 Jun 2026
- Mandate end
- 24 Jun 2026
- Anchor lock-in 50%
- 10 Jul 2026
- Anchor lock-in 100%
- 8 Sep 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative. Anchor lock-in applies only to issues with an anchor allotment.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| RII | 333shares 1 lot · ₹14,985 | 4,329shares 13 lots · ₹1,94,805 |
| sNII (₹2L–₹10L) | 4,662shares 14 lots · ₹2,09,790 | 21,978shares 66 lots · ₹9,89,010 |
| bNII (above ₹10L) | 22,311shares 67 lots · ₹10,03,995 | No limit funds permitting |
Based on the upper price band of ₹45 and a lot of 333 shares.
Issue structure
Face value
₹1 per share
Issue type
Bookbuilding IPO
Sale type
OFS only
Reservation
- QIB
- 1,54,29,851
- NII
- 46,28,956
- Retail
- 1,08,00,897
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 1.98 | 2.93 |
| P/E | 22.69 | 15.35 |
| Market cap | ₹553.13 Cr. | ₹653.80 Cr |
| KPI | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 13.02% | 10.47% |
| ROCE | 14.82% | 17.06% |
| Debt/Equity | 0.18 | 0.14 |
| RoNW | 12.12% | 12.46% |
| PAT Margin | 9.81% | 7.36% |
| EBITDA Margin | 14.03% | 12.33% |
| NAV | 18.15 | 15.91 |
| Price to Book Value | 2.48 | 2.83 |
Financials
| Metric | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Total income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit after tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| Net worth | 223.05 | 195.6 | 176.29 | 163.84 |
| Assets | 327.6 | 261.36 | 250.54 | 288.9 |
| Reserves & surplus | 210.92 | 183.89 | 164.51 | 152.3 |
| Total borrowing | 39.79 | 26.6 | 36.89 | 51.87 |
Figures in ₹ crore, as reported by the company in its offer document.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Sai Parenteral's Ltd.Mainboard | ₹392 | 72.19 | ₹405.70 | +3.49% |
| Corona Remedies Ltd.Mainboard | ₹1062 | 43.47 | ₹1,438.40 | +35.44% |
| Rubicon Research Ltd.Mainboard | ₹485 | 55.75 | ₹628.20 | +29.53% |
| Amanta Healthcare Ltd.Mainboard | ₹126 | 34.59 | ₹141.75 | +12.50% |
| Anlon Healthcare Ltd.Mainboard | ₹91 | 17.67 | ₹91.73 | +0.80% |
| Bio Medica Laboratories Ltd.SME | ₹139 | 13.03 | ₹115.80 | -16.69% |
| Goldline Pharmaceutical Ltd.SME | ₹43 | 10.47 | ₹56.77 | +32.02% |
| Speciality Medicines Ltd.SME | ₹124 | 9.27 | ₹125.90 | +1.53% |
| Accretion Nutraveda Ltd.SME | ₹129 | 26.27 | ₹191.20 | +48.22% |
| KRM Ayurveda Ltd.SME | ₹135 | 17.32 | ₹180.70 | +33.85% |
| Curis Lifesciences Ltd.SME | ₹128 | 12.44 | ₹141.00 | +10.16% |
| Aptus Pharma Ltd.SME | ₹70 | 11.29 | ₹84.84 | +21.20% |
| Asston Pharmaceuticals Ltd.SME | ₹123 | 17.83 | ₹124.95 | +1.59% |
| Influx Healthtech Ltd.SME | ₹96 | 13.04 | ₹126.20 | +31.46% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 27 Sep 2026. Always verify against the RHP before applying.